Divi's Lab.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE361B01024
  • NSEID: DIVISLAB
  • BSEID: 532488
INR
5,860.80
-46.15 (-0.78%)
BSENSE

Apr 02

BSE+NSE Vol: 5.31 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 509760,
    "name": "Divi's Lab.",
    "stock_name": "Divi's Lab.",
    "full_name": "Divis Laboratories Ltd",
    "name_url": "stocks-analysis/divi-s-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,860.80",
    "chg": -46.15,
    "chgp": "-0.78%",
    "dir": -1,
    "prev_price": "5,906.95",
    "mcapval": "150,684.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 532488,
    "symbol": "DIVISLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE361B01024",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "5.31 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/divi-s-lab-509760-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "509760",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/divis-laboratories-509760"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "31-Mar-2026",
      "details": "Intimation of closure of Trading Window from April 01 2026 till 48 hours of declaration of audited financial results for the quarter and financial year ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "21-Mar-2026",
      "details": "Intimation about Draft Order issued under Section 144C(1) of the Income Tax Act 1961 for FY2022-23.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Mar-2026",
      "details": "Newspaper clippings - Special Window for transfer and dematerialisation of physical shares.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07",
          "dt": "2007-08-03",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15",
          "dt": "2015-09-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Closure of Trading Window

31-Mar-2026 | Source : BSE

Intimation of closure of Trading Window from April 01 2026 till 48 hours of declaration of audited financial results for the quarter and financial year ended March 31 2026.

Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

21-Mar-2026 | Source : BSE

Intimation about Draft Order issued under Section 144C(1) of the Income Tax Act 1961 for FY2022-23.

Announcement under Regulation 30 (LODR)-Newspaper Publication

14-Mar-2026 | Source : BSE

Newspaper clippings - Special Window for transfer and dematerialisation of physical shares.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Divis Laboratories Ltd has declared 1500% dividend, ex-date: 25 Jul 25

stock-summary
SPLITS

Divis Laboratories Ltd has announced 2:10 stock split, ex-date: 03 Aug 07

stock-summary
BONUS

Divis Laboratories Ltd has announced 1:1 bonus issue, ex-date: 23 Sep 15

stock-summary
RIGHTS

No Rights history available